UNIGENE LABORATORIES INC
CIK 0000352747
Revenue (TTM)
$8.52M
−54.0% YoY
Q1 Apr 2013
Net Income (TTM)
−$16.97M
−383.2% YoY
Q1 Apr 2013
EPS Diluted (TTM)
−$0.21
+77.1% YoY
Q1 Apr 2013
Gross Margin
62.8%
Q1 Apr 2013
Operating Margin
-137.3%
Q1 Apr 2013
Net Margin
-199.2%
Q1 Apr 2013
Free Cash Flow (TTM)
−$3.41M
Q1 Apr 2013
Cash
$353.22K
Q1 Apr 2013
Total Debt
$137.79M
Q1 Apr 2013
Shares Outstanding
95.98M sh
Q1 Apr 2013